Breaking News
Get 45% Off 0
⬆ Upside Potential: Undervalued stocks with clear growth catalysts
See top stocks
Close

Cbt Vol 25 C (0P0000SUPE)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from a Portfolio Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
CBT Vol 25 historical data, for real-time data please try another search
140.370 -0.900    -0.64%
09/11 - Delayed Data. Currency in EUR
Type:  Fund
Market:  France
ISIN:  FR0011010024 
Asset Class:  Equity
  • Morningstar Rating:
  • Total Assets: 1.38M
CBT Vol 25 140.370 -0.900 -0.64%

0P0000SUPE Holdings

 
Comprehensive information about top holdings and Key Holding Information for the CBT Vol 25 (0P0000SUPE) fund. Our CBT Vol 25 portfolio information includes stock holdings, annual turnover, top 10 holdings, sector and asset allocation.

Asset Allocation

Create Alert
Add to Watchlist
Add to/Remove from a Portfolio  
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Name  Net %  Long %  Short %
Cash 6.950 15.690 8.740
Shares 79.140 79.140 0.000
Bonds 0.180 0.180 0.000
Convertible 0.010 0.010 0.000
Preferred 0.020 0.020 0.000
Other 13.710 13.710 0.000

 Style Box

Value & Growth Measures

Ratios Value Category Average
P/E Ratio 13.498 16.237
Price to Book 1.906 2.423
Price to Sales 1.240 1.823
Price to Cash Flow 6.518 9.881
Dividend Yield 2.602 2.477
5 Years Earnings Growth 11.497 10.735

Sector Allocation

Name  Net % Category Average
Technology 17.700 19.035
Financial Services 16.640 16.445
Industrials 14.000 12.290
Consumer Cyclical 13.710 11.951
Healthcare 9.000 11.848
Consumer Defensive 8.640 7.481
Basic Materials 7.440 6.978
Energy 5.810 4.895
Communication Services 3.910 7.525
Utilities 1.800 3.183
Real Estate 1.370 2.831

Region Allocation

  • North America
  • Latin America
  • Europe Developed
  • Asia
  • Australasia
  • Africa & Middle East
  • Emerging Markets
  • Developed Markets

Top Holdings

Number of long holdings: 9

Number of short holdings: 1

Name ISIN Weight % Last Change %
  Capital Group New Perspective Fund LUX Z LU1295554833 16.08 24.630 +0.12%
  Amundi Index Solutions - Amundi Index MSCI World I LU0996181599 15.77 3,554.290 +0.77%
  First Eagle Amundi International Fund Class AE-C S LU0565135745 15.76 255.270 +0.65%
  Roche-Brune Europe Actions I FR0011686930 13.72 1,910.000 +0.53%
AXA Rosenberg Glb Em Mkts Eq Alp A € Acc IE00B54FKV65 12.50 - -
Preval Funds SICAV - World Winners A EUR LU1132346872 12.07 - -
  MFS Meridian Funds Global Equity Fund A1 EUR LU0094560744 11.02 49.170 +0.31%
Banque - 3.15 - -
Rètro Fgs Indirect - 0.12 - -

Top Equity Funds by CBT Gestion

  Name Rating Total Assets YTD% 3Y% 10Y%
  CBT Vol 15 892.77K -9.28 0.88 -0.21
Comment Guidelines

We encourage you to use comments to engage with users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind: 

  • Enrich the conversation
  • Stay focused and on track. Only post material that’s relevant to the topic being discussed.
  • Be respectful. Even negative opinions can be framed positively and diplomatically.
  •  Use standard writing style. Include punctuation and upper and lower cases.
  • NOTE: Spam and/or promotional messages and links within a comment will be removed
  • Avoid profanity, slander or personal attacks directed at an author or another user.
  • Don’t Monopolize the Conversation. We appreciate passion and conviction, but we also believe strongly in giving everyone a chance to air their thoughts. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

0P0000SUPE Comments

Write your thoughts about Cbt Vol 25 C
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Apple
Continue with Google
or
Sign up with Email